Chronic Hepatitis C Virus Infection in Hemodialysis Patients: Treatment Outcomes and Drug-drug Interactions Management
Journal Title: Journal of Ankara University Faculty of Medicine - Year 2019, Vol 72, Issue 1
Abstract
Objectives: The aim of this study was to evaluate the success of the paritaprevir/ritonavir/ombitasvir/dasabuvir (PROD), ledipasvir/sofosbuvir (LDV/ SOF) and peginterferon (Peg-IFN) alfa-2a in the elimination of chronic hepatitis C virus (HCV) infection in HCV positive hemodialysis patients, and to assess the management of concomitant drug-drug interactions in patients receiving direct acting antiviral (DAA). Materials and Methods: The demographical characteristics, comorbid diseases, laboratory data, and treatment regimen and duration of 10 patients who were infected with HCV genotype 1 were retrospectively screened from the electronic hospital records. The patients were divided into 3 groups according to treatment regimen: PROD, LDV/SOF and Peg-IFN. Data on virologic response, adverse events, and biochemical and hematological parameters during and after therapy were analyzed. Also, concomitant drug use and drug-drug interactions were evaluated in patients receiving DAA regimen. Results: The median age was 48 (21-74) years, 5 (50%) of patients were female. 2 patients (20%) received LDV/SOF, 5 (50%) PROD and 3 (30%) Peg- IFN. Six of patients (60%) were HCV treatment-experienced and were failed to previous Peg-IFN therapy. All patients achieved sustained virologic response (100%). At the end of the one-year follow-up period, none of patients presented with HCV reactivation, and thus HCV was eliminated from our hemodialysis unit. No patient experienced serious adverse event leading to medication discontinuation during the course of treatment. Drug-drug interactions had to be modified with the treatment initiation in 2 out of 7 patients who received DAA. Conclusion: When multidrug use and comorbidities in hemodialysis patients are considered, multidisciplinary approach led by nephrologist are very important for increased access to treatment and more effective management of patients.
Authors and Affiliations
Şiyar Erdoğmuş
Keywords
Related Articles
- EP ID EP48689
- DOI 10.4274/atfm.galenos.2019.63522
- Views 260
- Downloads 0
Clinical and Laboratory Characteristics of Children and Adolescents with Hashimoto Thyroiditis at Diagnosis and During Follow-up
Objectives: The aim of this study was to evaluate the clinical and laboratory findings of children and adolescents with Hashimoto thyroiditis (HT) at diagnosis and during follow-up. Materials and Methods: Between Januar...
Frequency of Vitamin D Deficiency in Postmenopausal Women Who Live in Ankara Region
Objectives: The aim of this study is to define the frequency of vitamin D deficiency in postmenopausal women and to evaluate its implications on bone metabolism. Patients, who admitted to the Ankara University Faculty of...
The Frequency and Results of QuantiFERON-TB Gold Test in Parallel with the Place of the Clinical Usage in the Cerrahpaşa Medical Faculty Clinics: A 2-year Retrospective Evaluation
Objectives: We aimed to evaluate the relevancy of QuantiFERON-TB Gold (QFT) test which was required for the specific aims from the various clinics of Cerrahpaşa Medical Faculty by determining the using frequency and resu...
Ultrasound Imaging Findings of Subcutaneous Lumps and Bumps yerine Masses
Objectives: We aimed to investigate ultrasonography (US) imaging findings of palpable superficial soft-tissue masses in routine practice. Materials and Methods: We retrospectively investigated 92 patients with palpable...
3 Tesla MR Cihazında Beyin Diffüzyon Değerlerinde Hemisferik Farklılıklar
Objectives: The purpose of this study is to demonstrate the variability of the diffusion values in different anatomical regions of the brain. Materials and Methods: 3T diffusion MR images of 190 patients underwent brain...